"This is How Medical Institutions Became Captured!" | Joseph Figliolia
Joseph Figliolia's investigation into how American medical societies adopted positions on paediatric gender medicine without scrutinising the evidence carries a stark warning for Britain. His concept of a "citation cartel" — where a handful of associations cross-reference one another to lend false authority to weak claims — resonates directly with what the Cass Review uncovered about the evidence base underpinning NHS gender services. Understanding the mechanism of institutional capture helps explain how Tavistock persisted for so long, and why rebuilding trust in UK medical institutions requires structural reform, not merely policy revision.
Joseph Figliolia is a policy analyst at the Manhattan Institute, a New York-based think tank, and his focus in this conversation is a detailed examination of how the Texas Medical Association came to adopt official positions on paediatric gender medicine. His argument is not merely that these positions were wrong, but that the process by which they were reached was fundamentally broken. Medical societies, he contends, did not independently appraise the clinical evidence. Instead, they deferred to a narrow cluster of organisations — chief among them WPATH, the World Professional Association for Transgender Health — in what he describes as a citation cartel: a self-reinforcing loop in which a small number of bodies cite one another to manufacture the appearance of consensus. For British listeners, this framing is immediately recognisable. The Cass Review, published in April 2024, reached strikingly similar conclusions about the evidence base used to justify gender-affirmative treatment for children and young people in the NHS. Hilary Cass and her team found that the studies most frequently cited in favour of puberty blockers and cross-sex hormones were of poor quality, that systematic reviews had been conducted without the rigour expected in other areas of medicine, and that the field had developed an almost ideological resistance to scrutiny. The mechanism Figliolia describes in Texas appears to have operated in Britain too. Figliolia walks through specific examples of how this plays out in practice — including how a single contested study, such as the Tordoff paper frequently cited in this area, can become embedded in policy documents and repeated until it acquires unwarranted authority. He also examines the internal structures of medical associations, and particularly the role of reference committees, which can determine which resolutions reach a vote and in what form. These procedural levers, largely invisible to the public, are where capture happens quietly and incrementally. The Tavistock Gender Identity Development Service operated for years with relatively little challenge from the wider NHS establishment. What Figliolia's analysis helps explain is why institutional challenge is so difficult to mount: when the associations setting standards, the clinicians trained within those standards, and the journals publishing research all participate in the same closed loop, dissenting voices find themselves systematically excluded. This is not conspiracy — it is the predictable outcome of structures that reward consensus and punish deviation. For those following the reconstruction of NHS gender services after Tavistock's closure, the practical implications are significant. New clinical pathways and a fresh evidence framework are only as trustworthy as the institutions reviewing them. Figliolia's work is a reminder that reform requires interrogating the processes by which medical bodies form their positions, not simply replacing one set of guidelines with another. The Cass Review gave Britain a rare opportunity to do this honestly. Whether UK medical institutions seize that opportunity — or whether the citation cartel simply reconstitutes itself under new branding — remains an open question.
